AAV as a Gene Transfer Vector for the Treatment of Neurological Disorders: Novel Treatment Thoughts for ALS

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|9|5|428-433

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.9, Iss.5, 2009-10, pp. : 428-433

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

AAV-Mediated Gene Transfer for Treatment of Hemophilia

By  

Current Gene Therapy, Vol. 5, Iss. 3, 2005-06 ,pp. : 349-360

Bentham Science Publishers

Access to resources Recommend Favorite

Immunophilin ligands for the treatment of neurological disorders

By Hamilton G.S.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 9, 1998-09 ,pp. : 1109-1124

Informa Healthcare

Access to resources Recommend Favorite

Stem Cells for the Treatment of Neurological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 1, 2008-02 ,pp. : 98-109

Bentham Science Publishers

Access to resources Recommend Favorite

AAV-Mediated Gene Supply for Treatment of Degenerative and Neovascular Retinal Diseases

By  

Current Gene Therapy, Vol. 10, Iss. 5, 2010-01 ,pp. : 371-380

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Catechol-O-methyltransferase in the Treatment of Neurological Disorders

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 13, Iss. 3, 2013-09 ,pp. : 166-194

Bentham Science Publishers

Access to resources Recommend Favorite